UMediC Group Berhad (KLSE:UMC) Second Quarter 2023 Results

Key Financial Results

• Revenue: RM12.5m (up 69% from 2Q 2022).
• Net income: RM2.91m (up 412% from 2Q 2022).
• Profit margin: 23% (up from 7.7% in 2Q 2022). The increase in margin was driven by higher revenue.
• EPS: RM0.008 (up from RM0.002 in 2Q 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

UMediC Group Berhad Earnings Insights

Looking ahead, revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Healthcare industry in Malaysia.

Performance of the Malaysian Healthcare industry.

The company’s shares are up 12% from a week ago.

Risk Analysis

What about risks? Every company has them, and we’ve spotted 2 warning signs for UMediC Group Berhad (of which 1 is a bit concerning!) you should know about.

Articles from SimplyWall